NANOVIRICIDES, INC. Uncategorized Contracts & Agreements
18 Contracts & Agreements
- Letter from TheraCour Pharma, Inc (Filed With SEC on February 16, 2024)
- Extension Agreement between the Company and Dr. Anil R. Diwan, dated February 12, 2024 (Filed With SEC on February 16, 2024)
- Extension to CFO Agreement with Meeta Vyas effective July 1, 2023 (Filed With SEC on October 13, 2023)
- Form of Plan of Conversion (Filed With SEC on May 25, 2023)
- Form of Director Retainer Agreement (Filed With SEC on November 19, 2020)
- Director Retainer Agreement, dated as of May 15, 2020, between the Company and Mr. Rokita (Filed With SEC on May 19, 2020)
- Form of Director Retainer Agreement (Filed With SEC on February 11, 2020)
- Director Retainer Agreement (Filed With SEC on June 10, 2019)
- Placement Agent Agreement, dated February 27, 2019, by and between NanoViricides. and Chardan Capital Markets, LLC (Filed With SEC on March 1, 2019)
- Director Retainer Agreement (Filed With SEC on October 31, 2018)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 24, 2014)
- ******************** (Filed With SEC on January 24, 2014)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 13, 2013)
- ******************** (Filed With SEC on September 13, 2013)
- First Amendmentto SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 27, 2012)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 2, 2012)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 29, 2012)
- Underwriter Agent Agreement Amendment No. 1 (Filed With SEC on April 19, 2011)